Eric L Schneider

6PUBLICATIONS
6CO-AUTHORS
Pharmaceutical delivery technologiesMedical biochemistry - proteins and peptides (incl. medical proteomics)Solid tumoursInfant and child healthBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 03, 2025
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides.

Eric L Schneider, John A Hangasky, Gary W Ashley

|Nov 12, 2024
The limitation of lipidation: Conversion of semaglutide from once-weekly to once-monthly dosing.

Eric L Schneider, John A Hangasky, Rocío Del Valle Fernández

|Jun 19, 2024
Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors.

Elena Mironova, Sebastian Molinas, Vanessa Del Pozo

|Jul 20, 2022
A long-acting C-natriuretic peptide for achondroplasia.

Eric L Schneider, Christopher W Carreras, Ralph Reid

|Apr 06, 2021
Attenuation of the Reaction of Michael Acceptors with Biologically Important Nucleophiles.

Brian R Hearn, Shaun D Fontaine, Eric L Schneider

|Jun 13, 2017
A Hydrogel-Microsphere Drug Delivery System That Supports Once-Monthly Administration of a GLP-1 Receptor Agonist.

Eric L Schneider, Brian R Hearn, Samuel J Pfaff

Pageof 1

Frequent Collaborators

4 joint publications

Daniel V Santi

2 joint publications

John A Hangasky

1 joint publications

Christopher W Carreras

1 joint publications

Elena Mironova